Minimally invasive radical prostatectomy

Share this content:

The popularity of minimally invasive radical prostatectomy (MIRP) has risen despite lack of data on outcomes and higher costs compared with open retropubic radical prostatectomy (RRP), say US researchers. This population-based observational study compared outcomes among men with prostate cancer who underwent MIRP (n = 1,938) with those who had RRP (n = 6,899). Men who underwent MIRP had shorter hospital stays (median two versus three days for RRP), fewer respiratory and miscellaneous surgical complications and strictures, and a similar postoperative use of additional cancer therapies. However, they experienced more genitourinary complications (4.7 per cent versus 2.1 per cent for RRP), incontinence (15.9 versus 12.2 per 100 person-years) and erectile dysfunction (26.8 versus 19.2 per 100 person-years) than men who had RRP.

Hu JC, Gu X, Lipsitz SR et al. JAMA 2009;302(14):1557-64

Originally published in the December 2009 edition of MIMS Oncology & Palliative Care.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs